TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19459520

Group type: EXPERIMENTAL
Intervention: ARB (Telmisartan 80 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (ACE inhibitors only, Enalapril 40 mg/day)
Number of subjects: 80
Study: 16776692

Group type: COMPARATOR
Intervention: Cold pressor test (CPT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Heterotopic noxious conditioning stimulation (HNCS)
Number of subjects: 61
Study: 15110063

Group type: EXPERIMENTAL
Intervention: Healthy Steps (HS)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: PrePare (PP) + Healthy Steps (HS)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Intervention (HS or PP+HS)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Prenatal intervention (PP)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 439
Study: 11251427

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask (Fastrach)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 0
Study: 9934807

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg per day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8038358

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg t.d.s. plus tetracycline 500 mg q.d.s. for 14 days (OMP/TCN)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg in the morning plus tetracycline 500 mg q.d.s. along with bismuth subsalicylate tablets 2 q.d.s. for 14 days (OMP/TCN/BSS)
Number of subjects: 44
Study: 3055941

Group type: EXPERIMENTAL
Intervention: Tri-buffered aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31134713

Group type: EXPERIMENTAL
Intervention: Cogmed working memory training
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Concurrent Cogmed and metacognitive strategy training
Number of subjects: 95

Group type: COMPARATOR
Intervention: Adaptive visual search training (control group)
Number of subjects: 95
Study: 29400697

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 96

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 96
Study: 28061873

Group type: EXPERIMENTAL
Intervention: Melatonin 4 mg enterally administered once per day at 21:00 until ICU discharge or 14 days after enrolment, whichever occurs first.
Number of subjects: 850

Group type: COMPARATOR
Intervention: Placebo administered once per day at 21:00 until ICU discharge or 14 days after enrolment, whichever occurs first.
Number of subjects: 850
Study: 26488565

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 vaccine
Number of subjects: 4577

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4577
Study: 23159582

Group type: EXPERIMENTAL
Intervention: T pouch diversion after radical cystoprostatectomy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Studer pouch diversion after radical cystoprostatectomy
Number of subjects: 68
Study: 21513602

Group type: EXPERIMENTAL
Intervention: Chair-sitting exercise intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (semirecumbent position)
Number of subjects: 34
Study: 18381534

Group type: EXPERIMENTAL
Intervention: Fluconazole prophylaxis
Number of subjects: 6393
Study: 17048435

Group type: EXPERIMENTAL
Intervention: 300 mg DEC plus 400 mg ABZ
Number of subjects: 28

Group type: COMPARATOR
Intervention: 300 mg DEC alone
Number of subjects: 28
Study: 12663845

Group type: EXPERIMENTAL
Intervention: Stimulant users (cocaine or amphetamines)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Alcohol misusers only
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Alcohol and cannabis users
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Cannabis users only
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 233
Study: 10492061

Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil (1000/400 mg) with artesunate (250 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Atovaquone-proguanil (1000/400 mg) without artesunate
Number of subjects: 12
Study: 8909421

Group type: EXPERIMENTAL
Intervention: Weekly low-dose oral methotrexate
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced MRIs
Number of subjects: 56
Study: 2275513

Group type: EXPERIMENTAL
Intervention: Low-dosage oral contraceptives
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 280
Study: 453287

Group type: EXPERIMENTAL
Intervention: Chlorotrianisene (Tace)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31486620

Group type: EXPERIMENTAL
Intervention: QLB at L2
Number of subjects: 22

Group type: COMPARATOR
Intervention: QLB at L4
Number of subjects: 22
Study: 29160424

Group type: EXPERIMENTAL
Intervention: Prophylactic non-invasive ventilation (positive pressure 10 cm H2O, duration 1 hour, after 3 applications within the first 26 hours after extubation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard physical therapy without non-invasive ventilation)
Number of subjects: 50
Study: 26331110

Group type: EXPERIMENTAL
Intervention: Inspiron™ sirolimus‐eluting stent (SES)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cronus™ bare metal stent (BMS)
Number of subjects: 57
Study: 23898817

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural self-help (ICBT) combined with attention bias modification (ABM)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Internet-based cognitive-behavioural self-help (ICBT) combined with control training
Number of subjects: 133
Study: 22316073

Group type: EXPERIMENTAL
Intervention: Zinc (20 mg for children ≥ 12 months, and 10 mg for those < 12 months) once daily for seven days
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo once daily for seven days
Number of subjects: 352
Study: 20204996

Group type: EXPERIMENTAL
Intervention: If-then implementation intention
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Global implementation intention
Number of subjects: 557

Group type: COMPARATOR
Intervention: Control
Number of subjects: 557
Study: 17984834

Group type: EXPERIMENTAL
Intervention: Tacrolimus + Daclizumab (steroid-free)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Tacrolimus + Corticosteroids
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tacrolimus + Mycophenolate Mofetil (MMF) + Daclizumab (steroid-free)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Tacrolimus + MMF + Corticosteroids
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Steroid-free protocol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Corticosteroid protocol
Number of subjects: 70
Study: 16305899

Group type: EXPERIMENTAL
Intervention: Miniaturized cardiopulmonary bypass (MCPB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (CCPB)
Number of subjects: 30
Study: 12066265

Group type: EXPERIMENTAL
Intervention: Alumina ceramic bearings (345 hips)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Cobalt-chrome-on-polyethylene bearing (169 hips)
Number of subjects: 514
Study: 10371880

Group type: EXPERIMENTAL
Intervention: NUPRO Gold active gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo gel without the active agent
Number of subjects: 60
Study: 7631676

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation for 3 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo for 3 weeks
Number of subjects: 73
Study: 2449021

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cimetidine 1.6 g daily
Number of subjects: 50
Study: 30835574

Group type: EXPERIMENTAL
Intervention: Hormonal oral contraceptive use
Number of subjects: 16

Group type: COMPARATOR
Intervention: No hormonal contraceptive use
Number of subjects: 16
Study: 28874181

Group type: EXPERIMENTAL
Intervention: High protein and low glycemic index diet (1.3-1.4 g/kg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional diet (0.8-1.0 g/kg/day of protein)
Number of subjects: 120
Study: 25914962

Group type: EXPERIMENTAL
Intervention: Primary debulking surgery (PDS)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy with interval debulking (NACT‐IDS)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Optimally debulked patients
Number of subjects: 142
Study: 23340316

Group type: EXPERIMENTAL
Intervention: Soy milk
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cow's milk β casein A2
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cow's milk β casein A1
Number of subjects: 52

Group type: COMPARATOR
Intervention: Washout epoch
Number of subjects: 52
Study: 21170734

Group type: COMPARATOR
Intervention: 3,000 mg l⁻¹ clove solution for 40, 120, and 240 s exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 700 mg l⁻¹ clove solution for 40, 120, and 240 s exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 mg l⁻¹ clove solution for 40, 120, and 240 s exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 0
Study: 19008771

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (given to 69% of children)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (n = 174)
Number of subjects: 177
Study: 19770794

Group type: EXPERIMENTAL
Intervention: Simvastatin (lower than therapeutically equivalent dose)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Simvastatin (not prescribed a higher milligram dose)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Atorvastatin (control group)
Number of subjects: 383
Study: 16235158

Group type: EXPERIMENTAL
Intervention: InDuo
Number of subjects: 110
Study: 11176768

Group type: EXPERIMENTAL
Intervention: Scenario-based directive
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Value-based directive
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Discussion of directive with patient
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: No discussion of directive with patient
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control condition (no advance directive)
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Discussion interventions
Number of subjects: 401
Study: 9671009

Group type: EXPERIMENTAL
Intervention: Local investigator interpretation of admission ECG
Number of subjects: 516
Study: 8148290

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine with epinephrine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with epinephrine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Epinephrine (5 micrograms/mL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no epinephrine)
Number of subjects: 48
Study: 3061941

Group type: EXPERIMENTAL
Intervention: lorazepam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: diazepam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: alprazolam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: methaqualone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: benzodiazepines
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 28993404

Group type: EXPERIMENTAL
Intervention: AMPED intervention for secondary school PE teachers (workshops, online learning, implementation tasks, mentoring sessions)
Number of subjects: 1421

Group type: EXPERIMENTAL
Intervention: AMPED intervention for secondary school PE teachers
Number of subjects: 1421
Study: 30020510

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus trastuzumab with pertuzumab
Number of subjects: 370

Group type: COMPARATOR
Intervention: Chemotherapy plus trastuzumab without pertuzumab
Number of subjects: 370
Study: 26292796

Group type: EXPERIMENTAL
Intervention: Chewing exercises
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no vocal facilitating techniques)
Number of subjects: 27
Study: 24151990

Group type: EXPERIMENTAL
Intervention: Negative disconfirmation experience (worse than expected) in the high-risk estimate condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive disconfirmation experience (better than expected) in the low-risk estimate condition
Number of subjects: 0
Study: 22016458

Group type: EXPERIMENTAL
Intervention: MPFL reconstruction
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nonoperative treatment (immobilization and physiotherapy)
Number of subjects: 39
Study: 19282417

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Physiotherapy home exercise program
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) with stimulation
Number of subjects: 44
Study: 18067679

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with sulphadoxine‐pyrimethamine (SP)
Number of subjects: 1070
Study: 15504852

Group type: EXPERIMENTAL
Intervention: Day 14 assessment
Number of subjects: 13772

Group type: EXPERIMENTAL
Intervention: Day 28 assessment
Number of subjects: 13772

Group type: EXPERIMENTAL
Intervention: Overall failure rate
Number of subjects: 13772
Study: 11449082

Group type: EXPERIMENTAL
Intervention: Continuous combined oral HRT (2 mg of estradiol plus 1 mg of norethisterone acetate)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 22
Study: 9740348

Group type: EXPERIMENTAL
Intervention: Nurse-monitored outpatient-care programme
Number of subjects: 158

Group type: COMPARATOR
Intervention: Conventional care (usual care)
Number of subjects: 158
Study: 8113061

Group type: EXPERIMENTAL
Intervention: CATCH third-grade classroom curriculum
Number of subjects: 0
Study: 2844680

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 29980396

Group type: EXPERIMENTAL
Intervention: Measurable left ventricles
Number of subjects: 522

Group type: COMPARATOR
Intervention: No left ventricles
Number of subjects: 522
Study: 28025442

Group type: EXPERIMENTAL
Intervention: 1% Matricaria chamomilla L. mouthwash
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 25668505

Group type: EXPERIMENTAL
Intervention: Topical β-glucan
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control (follow-up only)
Number of subjects: 356
Study: 24119081

Group type: EXPERIMENTAL
Intervention: Enhanced postoperative care with frequent follow‐up by a care navigator (10 calls over 6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual postoperative care (no navigator phone calls)
Number of subjects: 0
Study: 21907115

Group type: EXPERIMENTAL
Intervention: Monocular distance visual acuity
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Monocular near visual acuity
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Comparison of distance and near visual acuity
Number of subjects: 129

Group type: COMPARATOR
Intervention: Distance visual acuity
Number of subjects: 129

Group type: COMPARATOR
Intervention: Near visual acuity
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Visual acuity difference analysis
Number of subjects: 129
Study: 18289829

Group type: EXPERIMENTAL
Intervention: Panic Online (PO), an internet‐based CBT intervention (n=46)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Best practice face‐to‐face CBT (n=40)
Number of subjects: 86
Study: 17050891

Group type: EXPERIMENTAL
Intervention: AMG 531 (3, 6, or 10 microg per kilogram)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AMG 531 (1 or 3 microg per kilogram)
Number of subjects: 45

Group type: COMPARATOR
Intervention: AMG 531 (1 microg per kilogram)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AMG 531 (3 microg per kilogram)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 13678479

Group type: EXPERIMENTAL
Intervention: Clarithromycin ER 500 mg once daily for 5 days
Number of subjects: 539

Group type: COMPARATOR
Intervention: Penicillin V 500 mg three times daily for 10 days
Number of subjects: 539
Study: 10490554

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment with alteplase
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Alteplase followed by transfer to the PTCA centre and rescue PTCA if indicated
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Transfer for primary PTCA
Number of subjects: 224
Study: 8739554

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg daily for 16 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg, SC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 0
Study: 2009163

Group type: EXPERIMENTAL
Intervention: Lightweight wheelchair
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard wheelchair
Number of subjects: 26
Study: 6765541

Group type: EXPERIMENTAL
Intervention: 15:85% human insulin mixture
Number of subjects: 9

Group type: COMPARATOR
Intervention: 10:90% human insulin mixture
Number of subjects: 9

Group type: COMPARATOR
Intervention: 20:80% human insulin mixture
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 15:85% and 20:80% human insulin mixtures
Number of subjects: 9
Study: 30188773

Group type: EXPERIMENTAL
Intervention: Generic Latanoprost (GL)
Number of subjects: 6317
Study: 27435303

Group type: EXPERIMENTAL
Intervention: Intravenous fish oil (FO) supplementation after the first week of PN
Number of subjects: 52

Group type: COMPARATOR
Intervention: Vegetal oil (control group)
Number of subjects: 52
Study: 26148915

Group type: EXPERIMENTAL
Intervention: Moderate red wine drinkers (≥ 1 drink/d)
Number of subjects: 5801

Group type: COMPARATOR
Intervention: Non-drinkers
Number of subjects: 5801
Study: 24766295

Group type: EXPERIMENTAL
Intervention: Rikkunshito (2.5 g three times a day for 8 weeks)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Rikkunshito
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Rikkunshito (among H. pylori-infected participants)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Rikkunshito (among H. pylori-uninfected participants)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Rikkunshito (among H. pylori-positive individuals)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo (three times a day for 8 weeks)
Number of subjects: 247
Study: 22926604

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (50 to 300 mg/d, mean = 132.2 mg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 19004846

Group type: EXPERIMENTAL
Intervention: Anacetrapib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 0
Study: 17691579

Group type: EXPERIMENTAL
Intervention: Acupuncture at bilateral cervical Jiaji (EX-B 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control acupuncture points: Fengchi (GB 20), Taichong (LR 3), Quchi (LI 11), Zusanli (ST 36), Sanyinjiao (SP 9)
Number of subjects: 60
Study: 15050907

Group type: EXPERIMENTAL
Intervention: Alendronate (40 mg daily in 3-month blocks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pamidronate (60 mg every 3 months as a single infusion)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Alendronate (40 mg daily) in previously untreated patients
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pamidronate in previously untreated patients
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Alendronate (40 mg daily) in previously treated patients
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pamidronate in previously treated patients
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Alendronate after crossover from pamidronate
Number of subjects: 72
Study: 11467466

Group type: EXPERIMENTAL
Intervention: Intervention not specified
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study: 10190530

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 7761376

Group type: EXPERIMENTAL
Intervention: Combination levorin + furadonin + nitroxoline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 2102704

Group type: EXPERIMENTAL
Intervention: 4-carbomethoxythiazolidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: N-acetyl-L-cysteine
Number of subjects: 20
Study: 7405545

Group type: EXPERIMENTAL
Intervention: Elective induction with oxytocin
Number of subjects: 81

Group type: COMPARATOR
Intervention: Spontaneous delivery
Number of subjects: 81
Study: 31219919

Group type: EXPERIMENTAL
Intervention: Reclassification of ASA-PS using pediatric-specific definitions
Number of subjects: 120
Study: 28738708

Group type: EXPERIMENTAL
Intervention: HBB 20 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HBB 40 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 26740049

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass graft surgery (OPCAB)
Number of subjects: 206

Group type: COMPARATOR
Intervention: On-pump coronary artery bypass graft surgery
Number of subjects: 206
Study: 24918911

Group type: EXPERIMENTAL
Intervention: Skeletonized radial artery (20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Radial artery with adjacent tissues (20 patients)
Number of subjects: 40
Study: 23116377

Group type: EXPERIMENTAL
Intervention: Children's Psychosocial Rehabilitation Treatment Adherence Measure (CTAM) for CPSR
Number of subjects: 106

Group type: COMPARATOR
Intervention: Children's Psychosocial Rehabilitation Treatment Adherence Measure (CTAM) for psychotherapy
Number of subjects: 106
Study: 20116388

Group type: EXPERIMENTAL
Intervention: Perceptual learning through computer displays depicting structure-from-motion (SFM) over three sessions a day for three consecutive days, each session comprising 48 trials.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (moderate AD) with no improvement in performance.
Number of subjects: 16
Study: 18705532

Group type: EXPERIMENTAL
Intervention: Fixed-dose amlodipine/benazepril (2.5/5 mg/day titrated to 5/10 mg/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Amlodipine monotherapy (5 mg/day titrated to 10 mg/day)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Fixed-dose amlodipine/benazepril
Number of subjects: 111

Group type: COMPARATOR
Intervention: Amlodipine monotherapy
Number of subjects: 111